Arterial Duct Stenting in Duct-Dependent Pulmonary Circulation: is Surgical Shunt Still Worthwhile?
Giuseppe Santoro*, Mario Giordano, Gianpiero Gaio, Maria Teresa Palladino, Carola Iacono and Maria Giovanna Russo
Paediatric Cardiology, II University of Naples, Italy
Submission: February 19, 2017; Published: April 28, 2017
*Corresponding author:Giuseppe Santoro, Paediatric Cardiology, II University of Naples, A.O.R.N. “Ospedali dei Colli”, Naples, Via Camillo Sorgente, 31 84125- Salerno, Italy, Tel:+39-081-7064275; Email: santoropino@tin.it
How to cite this article:Giuseppe S, Mario G, Gianpiero G, Maria Teresa P, Carola I, et al. Arterial Duct Stenting in Duct-Dependent Pulmonary Circulation: is Surgical Shunt Still Worthwhile?. J Cardiol & Cardiovasc Ther 2017; 4(5): 555650. DOI:10.19080/JOCCT.2017.04.555650
Introduction
It has long been realized that patients with congenital heart malformations resulting in duct-dependent pulmonary circulation would greatly benefit from stabilized pulmonary blood flow in view of spontaneous improvement or later lower-risk surgical repair. Although this aim may be achieved for a short period by continuous intravenous prostaglandin E infusion, a longer time stable pulmonary blood flow source must be provided in the vast majority of cases. Over time, different surgical systemic-to-pulmonary artery shunt techniques were proposed [1-4], with the main advantage of providing significant pulmonary blood flow increase for long time. However, size and angulations of the prosthetic conduit used to make either Blalock-Taussig or “central” shunts often resulted in pulmonary artery distortion and hypertension [5,6].
Maintaining arterial duct patency has long been proposed as an effective alternative to surgical systemic-to-pulmonary artery shunt in neonates who are unsuitable for primary repair or in whom there is anticipated spontaneous improvement of oxygen saturation as pulmonary vascular resistance decreases. Using arterial duct as a native systemic-to-pulmonary communication was first reported in lambs submitted to surgical duct formaldehyde infiltration [7]. Rudolph et al. [8] extended this concept to newborns with cyanotic congenital heart disease, whose arterial duct was surgically exposed and infiltrated with 10% buffered formaldehyde with resulting significant and long-lasting clinical improvement. Further evolution of this idea was trans-catheter stabilization of arterial duct by balloon angioplasty, although the initial experimental studies were disappointing and hampered a wide clinical application of this approach [9-11]. Arterialduct stabilization by stent implantation to achieve a durable patency was then considered as the “Columbus egg” in clinical setting of duct-dependent congenital heart malformations. Indeed, this option makes possible to finely tailor shunt magnitude to individual patient. In addition, in the case of very low-weight neonates, stent diameter might be progressively increased by serial balloon dilatations to adapt the shunt flow to the patient growth. Finally, allowing the stent to conform to the pulmonary artery anatomy might have favourable effects on development of the pulmonary vascular tree due to even distribution of pulmonary blood flow. Following the early experiences in animal models [12,13], this approach was then performed in cyanotic neonates with conflicting results in terms of failure rate, early complications and mid-term outcome [14-18]. Over time, technical improvement of stents and delivery systems made percutaneous duct stenting safer and more feasible as short-term palliation of duct-dependent neonates and young infants, with success rate around 90%, morbidity rate less than 10% and no procedural mortality [19-22]. Procedural failures and complications were mainly due to ductal tortuosity and in-stent hyperplasia/thrombosis, respectively. In addition, this approach was cost-effective either in low-risk patients or in clinical and/or anatomical high-risk ones [22-29]. In addition, arterial duct stenting revealed more “physiologic” with respect to surgical shunt since resulted in a better distribution of pulmonary blood flow with consequent more balanced pulmonary artery growth [30-32]. Effective and balanced pulmonary artery growth was shown either in standard or in challenging anatomic settings [33-35].
Inclusion criteria to arterial duct stenting program could be roughly set as follows:
- Patients with high-risk profile for conventional surgical palliation due to significant co-morbidities or with unusual anatomic arrangement of the pulmonary arteries (for example, with the arterial duct serving a discontinuous pulmonary artery or with bilateral ducts serving isolated pulmonary arteries.
- Patients with anticipated need for a short-term support to pulmonary circulation as in pulmonary atresia with intact ventricular septum after successful radiofrequency pulmonary valve perforation or in critically cyanosed neonates due to Ebstein’s anomaly of the tricuspid valve and functional pulmonary atresia.
- Patients with complex cardiac malformations with uni-ventricular physiology destined to the Fontan operation as a bridge toward an early cavo-pulmonary an astomosis.
- Elective alternative to systemic-to-pulmonary artery shunt in low-risk neonates in whom early surgical repair may be planned.
The main aims to pursue in the next future should be to increase feasibility rate of duct stabilization in patients with very tortuous arterial ducts and to prolong life-span of the stented duct. Both these advances might universally extend this approach also to include patients with planned surgical repair in late childhood. Newer technologies should give significant answers to these questions. The former goal might be attained with the use of new, very pliable, self-expandable stents that can be deployed using smaller and more easily trackable delivery sheaths. The latter goal might be based on the use of drug-eluting stents, provided evidence-based safety of the released drug, or more flexible covered stents that can be deployed through smaller delivery sheaths. Clinical trial restricted to single centres with special expertise and experience might give final answers to these questions.
References
- Blalock A, Taussig H (1945) The surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. JAMA 128(3): 189-202.
- Potts WJ, Smith S, Gibson S (1946) Anastomosis of the aorta to a pulmonary artery, certain types in congenital heart disease. J Am Med Assoc 132(11): 627-631.
- Waterston DJ (1962) Treatment of Fallot’s tetralogy in children under one year of age. Rozhl Chir 41: 181-183.
- Tamisier D, Vouhe PR, Vermant F, Leca F, Massoat C, et al. (1990) Modified Blalock Taussig shunts: results in infants less than 3 months of age. Ann Thorac Surg 49(5): 797-801.
- Fermanis GG, Ekangaki AK, Salmon AP, Keeton BR, Shore DF, et al. (1992) Twelve year experience with the modified Blalock-Taussig shunt in neonates. Eur J Cardiothorac Surg 6(11): 586-589.
- Potapov EV, Alexi-Maskishvili VV, Dahnert I, Ivanitskaia EA, Lange PE, et al. (2001) Development of pulmonary arteries after central aortopulmonary shunt in newborns. Ann Thorac Surg 71(3): 899-906.
- Lakier JB, Heymann MA, Rudolph AM (1974) Inhibition of closure of the ductus arteriosus. Pediatr Res 8: 351-360.
- Rudolph AM, Heymann MA, Fishman N, Lakier JB (1975) Formalin infiltration of the ductus arteriosus. A method for palliation of infants with selected congenital cardiac lesions. N Engl J Med 292(24): 1263- 1268.
- Lund G, Cragg A, Rysavy J, Castaneda F, Salomonowitz E, et al. (1983) Patency of the ductus arteriosus after balloon dilatation: an experimental study. Circulation 68: 621-627.
- Lund G, Rysavy J, Cragg A, Salomonowitz E, Vlodaver Z, et al. (1984) Long-term patency of the ductus arteriosus after balloon dilatation: an experimental study. Circulation 69: 772-774.
- Abrams SE, Walsh KP, Diamond MJ, Clarkson MJ, Sibbons P (1994) Radiofrequency thermal angioplasty maintains arterial duct patency. An experimental study. Circulation 90: 442-448.
- Coe JY, Olley PM (1991) A novel method to maintain ductus arteriosus patency. J Am Coll Cardiol 18(3): 837-841.
- Moore JW, Kirby WC, Lovett EJ, O’ Neill JT (1991) Use of an intravascular prosthesis (stent) to establish and maintain short-term patency of the ductus arteriosus in new born lambs. Cardiovasc Interv Radiol 14(5): 299-301.
- Gibbs JL, Rothman MT, Rees MR, Parsons JM, Blackburn ME, et al. (1992) Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Br Heart J 67(3): 240-245.
- Schneider M, Zartner P, Sidiropouluos A, Konertz W, Hausdorf G (1998) Stent implantation of the arterial duct in newborns with ductdependent circulation. Eur Heart J 19(9): 1401-1409.
- Gibbs JL, Uzun O, Blackburn MEC, Wren C, Hamilton L, et al. (1999) Fate of the stented arterial duct. Circulation 99(20): 2621-2625.
- Michel-Behnke I, Akiturch H, Thul J, Bauer J, Hagel KJ, et al. (2004) Stent implantation in the ductus arteriosus for pulmonary blood supply in congenital heart disease. Cathet Cardiovasc Interv 61(2): 242-252
- Alwi M, Choo KK, Latiff HA, Kandavello G, Samion H, et al. (2004) Initial results and medium term follow up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. J Am Coll Cardiol 44(2): 438-445.
- Gewillig M, Boshoff DE, Dens J, Mertens L, Benson LN (2004) Stenting the neonatal arterial duct in duct-dependent pulmonary circulation: new techniques, better results. J Am Coll Cardiol 43(1): 107-112.
- Santoro G, Gaio G, Palladino MT, Iacono C, Carrozza M, et al. (2008) Stenting of the arterial duct in newborns with duct-dependent pulmonary circulation. Heart 94(7): 925-929.
- Udink Ten Cate FE, Sreeram N, Hamza H, Agha H, Rosenthal E, et al. (2013) Stenting the arterial duct in neonates and infants with congenital heart disease and duct-dependent pulmonary blood flow: A multicenter experience of an evolving therapy over 18 years. Catheter Cardiovasc Interv 82(3): E233-E243.
- Santoro G, Gaio G, Giugno L, Capogrosso C, Palladino MT, et al. (2015) Ten-years, Single-centre Experience with Arterial Duct Stenting in Duct-dependent Pulmonary Circulation: Early Results, Learning-curve Changes and Mid-term Outcome. Cathet Cardiovasc Interv 86(2): 249- 257.
- Santoro G, Bigazzi MC, Palladino MT, Russo MG, Carrozza M, et al. (2005) Transcatheter palliation of tetralogy of Fallot with pulmonary artery discontinuity. Tex Heart Inst J 32(1): 102-104.
- Butera G, Santoro G, Calabrò R, Carminati M (2008) Percutaneous treatment of ductal origin of the distal pulmonary artery in low-weight newborns. J Invasive Cardiol 20(7): 354-356.
- Santoro G, Caianiello G, Russo MG, Calabrò R (2008) Stenting of bilateral arterial ducts in complex congenital heart disease. Ped Cardiol 29(4): 842-845.
- Santoro G, Gaio G, Palladino MT, Carrozza M, Iacono C, et al. (2008) Transcatheter ductal stenting in critical neonatal Ebstein’s anomaly. J Cardiovasc Med 9(4): 419-422.
- Santoro G, Palladino MT, Russo MG, Calabrò R (2008) Neonatal patent ductus arteriosus recanalization and “stenting” in critical Ebstein’s anomaly. Pediatr Cardiol 29(1): 176-179.
- Santoro G, Caianiello G, Gaio G, Palladino MT, Marrone C, et al. (2009) Late percutaneous recanalization of duct-dependent isolated pulmonary artery. J Cardiovasc Med 11(3): 196-198.
- Santoro G, Gaio G, Castaldi B, Palladino MT, Iacono C, et al. (2011) Arterial Duct Stenting in Low-weight Newborns with Duct-dependent Pulmonary Circulation. Cathet Cardiovasc Interv 78(5): 677-685.
- Santoro G, Capozzi G, Caianiello G, Palladino MT, Marrone C, et al. (2009) Pulmonary artery growth after palliation of congenital heart disease with duct-dependent pulmonary circulation: arterial duct stenting versus surgical shunt. J Am Coll Cardiol 54(23): 2180-2186.
- Mallula K, Vaughn G, El-Said H, Lamberti JJ, Moore JW (2015) Comparison of ductal stenting versus surgical shunts for palliation of patients with pulmonary atresia and intact ventricular septum. Cathet Cardiovasc Interv 85(7): 1196-1202.
- McMullan DM, Permut LC, Jones TK, Johnston TA, Rubio AE (2014) Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow. J Thorac Cardiovasc Surg 147(1): 397-401.
- Santoro G, Palladino MT, Capozzi G, Iacono C, Russo MG, et al. (2009) Pulmonary artery growth following arterial duct stenting in congenital heart disease with duct-dependent pulmonary circulation. Cathet Cardiovasc Interv 74(7): 1072-1076.
- Santoro G, Gaio G, Capozzi G, Giugno L, Palladino MT, et al. (2015) Fate of Hypoplastic Pulmonary Arteries After Arterial Duct Stenting in Congenital Heart Disease With Duct-Dependent Pulmonary Circulation. JACC Cardiovasc Interv 8(12): 1626-1632.
- Santoro G, Capozzi G, Capogrosso C, Mahmoud HT, Gaio G, et al. (2016) Pulmonary artery growth after arterial duct stenting in completely duct-dependent pulmonary circulation. Heart 102(6): 459-464.